According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Oric Pharmaceuticals Inc. (ORIC) has announced the launch of an equity offering plan.

According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Oric Pharmaceuticals Inc. (ORIC) has announced the launch of an equity offering plan.

老虎证券2026/02/23 22:35

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The company will authorize the underwriter Jefferies to periodically issue common stock to the market at appropriate times in the future, with a total fundraising scale of up to $200 million. Such "shelf offering" arrangements provide listed companies with flexible financing channels, allowing them to issue shares in batches according to market conditions and funding needs. This financing plan will support Oric Pharmaceuticals in advancing its pipeline of targeted oncology therapies. By appointing Jefferies as the sales agent, the company can more efficiently seize market windows and optimize its financing structure.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Duan Yongping has made it clear that he will not sell Nvidia and sold a large number of put options on the day the news was released. Nvidia may invite Jensen Huang to serve as an advisor, taking on a “shadow CEO” role to retain his influence, but he would no longer have signing authority. Whether this scenario materializes will likely only become clear after the hearing concludes.

华尔街见闻•2026/11/13 07:48